Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Helge Waldum MD

Helge L. Waldum MD

Professor, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway

Head of Department of Gastroenterology and Hepatology, St. Olavs Hospital, Trondheim for 20 years and professor for 35 years at Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway

MD, University of Oslo, Norway, second best result ever and reported to the King.

Specialist in Internal Medicine and Gastroenterology 1980.

  • Thesis (PhD), University of Tromsø, Norway 1980: “Studies on group I pepsinogens and secretin”

  • Thésis, Docteur d‘Etat, Paris 1993 :« La cellule ECL, une cellule clé dans la muquese gastric » (Très honorable avec félicitations)

  • One year of Research fellowship at Hôpital Bichat Paris 1987-1988.

    Diplôme d'études approfondies de biologie cellulaire et fonctionnelle des processus digestifs. Année 1987-1988. Responsable : Professeur S. Bonfils - Paris VII.

  • Research within the areas of gastric acid secretion, gastrointestinal hormones, gastric pathology and tumour classification, the cell of origin not only for gastric but also renal cancer, carcinogenesis, the role of neuroendocrine cells in carcinogenesis, differentiated contra stem cell origin of cancers (paradigm shift?), neuroendocrine markers (chromogranin A), gastric markers (pepsinogens), problems related to inhibition of gastric acid secretion, nicotine and CO inhalation toxicity, and carcinoid disease with valvular heart disease.

  • Serotonin and cardiac valvular disease in general.

Recent Contributions to PracticeUpdate:

  1. Long-Term Natural History of Autoimmune Gastritis

Recently Updated